Skip to main content
Premium Trial:

Request an Annual Quote

Research Data Scientist, Computational Biology of Aging



Job Location

1445A South 50th Street
Richmond, CA 94804
United States


BioAge offers a comprehensive compensation package, as well as generous paid time off in addition to company-observed holidays. We provide medical, dental, and vision insurance, along with a 401(k) retirement savings plan which includes matching employer contributions. We also pride ourselves in giving employees many opportunities for career development including a generous annual budget for continued learning, a direct and open-door environment, and a dedication to training and skill development.

Job Description

We are seeking a highly motivated, independent, and creative computational biologist to develop and apply techniques in machine learning to elucidate fundamental drivers of human aging. The major research focus will be the discovery and investigation of biomarker signatures, biological pathways, and drug targets related to biological aging, healthspan, and lifespan in humans using ML on unique human aging datasets generated by BioAge and our partners. The key focuses for this position will be the timely publication of results in high-impact journals, and development work on our proprietary AI Platform


  • Candidates should have a Ph.D. in computational biology or a related discipline
  • Strong background in machine learning and statistics, as well as an interest in the biological processes that drive aging
  • Publications and knowledge in ML methods development, aging biology, molecular biology, medicine, and/or drug discovery will be highly valuable
  • Experience working with and integrating proteomic, metabolomic, transcriptomic, genomic, and/or methylation data is also an asset
  • This is a remote working position with no travel requirements

How to Apply

About Our Organization

BioAge Labs is a clinical-stage venture-backed biotechnology company headquartered in Richmond, CA. We’ve built a systems biology platform to map out the key molecular pathways that impact healthy human aging, based on proprietary human aging cohorts that have blood samples collected up to 45 years ago with participant-omics data that is tied to detailed medical follow-up records over their lifespan. To date, BioAge has raised $127M from Andreessen Horowitz, Kaiser Foundation Hospitals, and others. Recently, BioAge in-licensed our first two platform assets, and for both programs, we’ll be initiating Phase 2 efficacy trials by H1 2021. Our mission is to develop a pipeline of therapeutic assets that increase healthspan and lifespan.

Career Blog headlines

Enrollment Down

According to the Chronicle of Higher Education, enrollment at colleges and universities in the US was down this spring, as compared to 2020.

The Pandemic and Women in STEM

The New York Times reports on how the COVID-19 pandemic may affect women in STEM.

Missing from the Top

A new report finds that women, especially women of color, are missing among the high-earners at research universities in the US, the Chronicle of Higher Education writes. 

Time Lost

Researcher-parents, especially mothers of small children, have lost research time during the COVID-19 pandemic, according to the Chronicle of Higher Education.